Two levels working as one system. The fund base gives the operating partner cross-portfolio intelligence and high-stakes lifecycle support. The per-company fee deploys the full BLUE architecture — 9 senior roles, 58 sub-agents — into every portfolio company from day one.
CYPHR COBALT operates on two simultaneous planes. At the fund level, the operating partner has a cross-portfolio view — compliance dashboards spanning every acquisition, regulatory intelligence centralized rather than siloed, and dedicated capacity for the moments that define investment outcomes: due diligence sprints, and exit preparation.
At the portfolio company level, each acquisition receives the complete BLUE architecture — the same 9 senior roles and 58 sub-agents that a standalone healthcare organization engagement would deploy. There are no tiers at the company level. No light versions for smaller acquisitions. Full institutional infrastructure into every company.
Aether provides the coordination layer — enabling cross-portfolio pattern recognition and benchmarking while maintaining strict data segregation between portfolio companies. The fund sees patterns; no portfolio company sees another's data.
The operating partner receives dedicated cross-portfolio infrastructure — not a per-company advisory engagement, but GP-level intelligence and capacity that spans the entire portfolio. This is the layer that makes a PE operating model possible at healthcare scale.
A unified compliance posture view across every portfolio company. Regulatory status, open issues, remediation progress, and risk flags — visible to the operating partner across all acquisitions simultaneously.
Healthcare regulatory changes — CMS rule updates, HIPAA guidance, state licensure changes, payer policy shifts — tracked centrally and assessed for impact across the portfolio, not company by company.
Rapid compliance posture assessment, revenue cycle diagnostic, and operational gap analysis for new acquisition targets. Compressed timelines. Actionable findings calibrated to investment decision-making.
Comprehensive exit preparation: change of ownership applications, provider re-enrollment coordination, facility license transfers, payer contract assignment, and compliance documentation packages for buyer due diligence.
Operational performance benchmarking across portfolio companies — revenue cycle metrics, compliance program maturity, payer mix performance, and clinical quality indicators — enabling portfolio-level value creation tracking.
Early warning intelligence across regulatory, operational, and financial risk vectors — surfacing issues at the portfolio company level before they become fund-level problems.
Every portfolio company receives the complete BLUE architecture. The same 9 senior healthcare operations roles and 58 sub-agents that a standalone healthcare organization engagement deploys — activated at acquisition, running continuously through exit. No tiers. No light versions. Full institutional deployment every time.
Aether identifies regulatory risk patterns, compliance gap profiles, and remediation trajectories across portfolio companies — enabling the operating partner to identify systemic issues and standardize responses at scale. Each company's underlying data remains segregated.
Denial rates, days in A/R, coding accuracy scores, payer mix performance — benchmarked across the portfolio anonymously. Identifies outliers, best practices, and value creation opportunities that are invisible at the company level.
No portfolio company has visibility into another company's data. Cross-portfolio analytics are derived from anonymized, aggregated patterns only. The fund sees the portfolio view; each company sees only its own data. Data segregation is structural, enforced by Aether's architecture.
Aether maintains engagement memory from acquisition through exit — prior compliance analyses, remediation histories, payer contract terms, operational decisions. Exit documentation is not reconstructed; it is maintained continuously from day one.
The fund base is built. The BLUE architecture is ready. The question is how COBALT fits your fund structure and portfolio company count.
CYPHR COBALT provides healthcare operations advisory services for PE-owned healthcare organizations. CYPHR does not provide legal, medical, or clinical care services. Role descriptions represent advisory and analytical functions performed in support of healthcare organizations. All engagements require formal terms of service. CYPHR COBALT is a division of CYPHR Group.